Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Studies from Mustafa Kemal University, Medical Department update current data on immunization
December 10th, 2008
According to a study from Hatay, Turkey, "The aim of this study was to investigate whether haemodialysis (HD) patients suffering from diabetes mellitus could be considered at risk for the development of the protective antibodies to hepatitis B (HB) vaccination and, to evaluate the effectiveness of tetanus toxoid (TT) administrated 2 days before HB vaccination. Forty-nine HD patients were divided into two groups: group A (19 diabetic patients) and group B (30 non-diabetic patients)." "A dose of 40 mg recombinant HB vaccine was injected intramuscularly to the patients at 0, 1, 2 and 6 months. After the completion of the course, the patients in group A were found to have a...
Source: Vaccine Weekly (2008-12-10)
|
